MAL2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.762000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.660420E-01
Normal-vs-Stage2
6.764200E-02
Normal-vs-Stage3
3.083800E-01
Normal-vs-Stage4
9.435900E-02
Stage1-vs-Stage2
8.227800E-01
Stage1-vs-Stage3
8.195200E-01
Stage1-vs-Stage4
4.666600E-01
Stage2-vs-Stage3
6.119200E-01
Stage2-vs-Stage4
3.788400E-01
Stage3-vs-Stage4
4.324000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.336100E-02
Normal-vs-AfricanAmerican
1.807560E-01
Normal-vs-Asian
7.568100E-02
Caucasian-vs-AfricanAmerican
4.597800E-01
Caucasian-vs-Asian
2.980800E-01
AfricanAmerican-vs-Asian
2.450200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.892400E-02
Normal-vs-Female
8.082200E-02
Male-vs-Female
4.434600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.548400E-01
Normal-vs-Age(41-60Yrs)
6.152000E-02
Normal-vs-Age(61-80Yrs)
7.776100E-02
Normal-vs-Age(81-100Yrs)
8.161800E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.190800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.155400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.084800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.202700E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.216400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.516000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.196400E-02
Normal-vs-Daily Drinker
1.207850E-01
Normal-vs-Weekly Drinker
2.036800E-01
Normal-vs-Occasional Drinker
4.422200E-02
Normal-vs-Social Drinker
2.854100E-02
Non Drinker-vs-Daily Drinker
7.853200E-01
Non Drinker-vs-Weekly Drinker
5.258000E-01
Non Drinker-vs-Occasional Drinker
4.842300E-02
Non Drinker-vs-Social Drinker
1.854770E-01
Daily Drinker-vs-Weekly Drinker
4.749200E-01
Daily Drinker-vs-Occasional Drinker
1.500020E-01
Daily Drinker-vs-Social Drinker
2.034400E-01
Weekly Drinker-vs-Occasional Drinker
5.664100E-02
Weekly Drinker-vs-Social Drinker
7.801400E-01
Occasional Drinker-vs-Social Drinker
1.060160E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.600760E-01
Normal-vs-Grade 2
4.137700E-02
Normal-vs-Grade 3
3.506500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.921800E-02
Grade 1-vs-Grade 3
1.830270E-02
Grade 1-vs-Grade 4
1.600760E-01
Grade 2-vs-Grade 3
1.802020E-01
Grade 2-vs-Grade 4
4.137700E-02
Grade 3-vs-Grade 4
3.506500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.067960E-01
Normal-vs-NonDiabetic
7.332500E-02
Diabetic-vs-NonDiabetic
1.415930E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.161800E-02
Normal-vs-NoPancreatitis
9.707800E-02
Pancreatitis-vs-NoPancreatitis
3.750000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.660300E-02
Normal-vs-N1
7.448500E-02
N0-vs-N1
3.845800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.742400E-03
Normal-vs-TP53-NonMutant
1.209790E-01
TP53-Mutant-vs-TP53-NonMutant
6.65778543407214E-12
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
